MOONSTONE/GOG-3032: A phase II, open-label, single-arm study to evaluate the efficacy and safety of niraparib + dostarlimab in patients with platinum-resistant ovarian cancer Meeting Abstract
| Authors: | Randall, L. M.; O'Malley, D. M.; Monk, B. J.; Coleman, R. L.; O'Cearbhaill, R. E.; Gaillard, S.; Adams, S.; Cappuccini, F.; Huang, M.; Chon, H. S.; Secord, A. A.; Arora, S.; Keeton, E.; Gupta, D.; Samnotra, V.; Konstantinopoulos, P. |
| Abstract Title: | MOONSTONE/GOG-3032: A phase II, open-label, single-arm study to evaluate the efficacy and safety of niraparib + dostarlimab in patients with platinum-resistant ovarian cancer |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S646 |
| End Page: | S647 |
| Language: | English |
| ACCESSION: | WOS:000573469101171 |
| DOI: | 10.1016/j.annonc.2020.08.1022 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 883TiP -- Source: Wos |
